Label: DYNAREX ANTIFUNGAL POWDER- miconazole powder

  • NDC Code(s): 67777-316-01, 67777-316-02
  • Packager: Dynarex Corporation
  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: OTC monograph final

DISCLAIMER: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Drug Label Information

Updated November 29, 2022

If you are a consumer or patient please visit this version.

  • Active Ingredient

    Active Ingredient                     Purpose

    Miconazol 2%                          Antifungal

  • Purpose

    Uses

    For external treatment of fungal infections such as athlete’s foot, jock itch, sweat rash, infected diaper rash and fungal infections affecting the skin folds e.g. armpits, groin, or under the breasts.

  • Warnings

    For external use only.

    Consult a doctor or pharmacist before using this product if you:

    ■ Are sensitive to the listed ingredients or any similar medications ■ Are pregnant, planning a pregnancy or breastfeeding

    When using this product:

    You may occasionally experience some side effects. These are rare and consist of local skin irritation or rashes, which occur if you are unusually sensitive to the ingredients listed.

  • Do Not Use

    Do not use:

    ■ if you are sensitive to any of the active or inactive ingredients listed ■ if the infection is on your scalp or nails.

  • Cautions

    Please read this label carefully before use.

    • Dynarex Antifungal Powder is not suitable for the treatment of fungal infections of the scalp or nails, and you should talk to your doctor or pharmacist for alternative treatments for these conditions. In order to ensure successful treatment, it is important to use the powder regularly and to continue for at least 10 days after the disappearance of symptoms. This prevents the infection from reoccurring.

    • Remember that most fungal infections are very infectious and can easily be passed on to other family members. In order to prevent this happening, it is important to ensure that anyone who has an infection avoids sharing clothes, towels, or shoes with other family members. After applying the powder, wash and dry your hands thoroughly. If your skin condition does not improve after one week’s use, please consult your doctor or pharmacist.

    • If you forget to apply the powder, do not apply the missed dose, but apply the next dose as usual and continue as normal. Do not apply two doses at the same time.

    Interactions

    If you are taking oral anticoagulants (drugs used to thin the blood, such as Warfarin), talk to your doctor or pharmacist before use.

    Overdose

    Excessive use can result in skin irritation, which usually disappears after discontinuation of therapy. In case of accidental ingestion of powder go to the hospital immediately.

  • Directions

    Sprinkle onto the affected area twice daily. It can be safely applied to broken skin and may also be sprinkled onto clothes and footwear, which come into contact with the infected area.

  • Other information

    Keep the medicine in the original packaging in a dry place, at a temperature not exceeding 30ºC/86ºF. Protect from light. Do not use after the expiry date shown on the pack.

  • Keep Out Of Reach Of Children

    Keep Out Of Reach Of Children

    Do not let the powder get into your eyes. This product contains talc. Do not breathe in the powder as this may cause irritation of the airways. This is especially important for children and infants. If swallowed, contact a poison control center immediately.

  • Inactive ingredients

    Colloidal silicon dioxide, talc.

  • Principal Display panel

    Dynarex Antifungal Powder 1236

    AntiPowGP.jpg

    Antifungal Powder

  • INGREDIENTS AND APPEARANCE
    DYNAREX ANTIFUNGAL POWDER 
    miconazole powder
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:67777-316
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    MICONAZOLE NITRATE (UNII: VW4H1CYW1K) (MICONAZOLE - UNII:7NNO0D7S5M) MICONAZOLE NITRATE20 mg  in 1 g
    Inactive Ingredients
    Ingredient NameStrength
    SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
    TALC (UNII: 7SEV7J4R1U)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:67777-316-0224 in 1 CASE05/19/2016
    1NDC:67777-316-0185 g in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC monograph finalpart333C05/19/2016
    Labeler - Dynarex Corporation (008124539)
    Registrant - Dynarex Corporation (008124539)